发明名称 NMR-METHOD FOR DETERMINING THE RISK OF DEVELOPING TYPE 2 DIABETES
摘要 Methods for assessing the risk of developing Type 2 diabetes and other relat ed disorders include obtaining an NMR derived reference spectrum for a known glucose concentration sample and storing this information as a reference standard. A patient blood sample is collected and NRM derived patient spectrums for the blood sample are obtained. The two NMR data sets (the reference and the patient) are compared and a glucose concentration is determined for the patient sample. The glucose concentration can be evaluate d with a blood sample undergoing lipoprotein cholesterol evaluation. The NMR based test can be used to concurrently provide a glucose concentration and lipoprotein constituent values based on a single testing event. The disclosu re also includes a multi-purpose test, i.e., a test which concurrently provides lipoprotein screening and coronary heart disease risk evaluation along with a diabetes screening and risk assessment for developing Type 2 diabetes. A method for assessing diabetes includes identifying the presence of diabetic dyslipidemia based on the values of predetermined NMR measured lipoprotein constituents.
申请公布号 CA2367820(A1) 申请公布日期 2000.11.02
申请号 CA20002367820 申请日期 2000.04.19
申请人 LIPOMED, INC.;NORTH CAROLINA STATE UNIVERSITY 发明人 BENNETT, DENNIS W.;OTVOS, JAMES D.
分类号 G01N24/08;G01N33/483;G01N33/53;G01N33/66;G01N33/68;G01N33/74;G01R33/465;(IPC1-7):G01R33/46 主分类号 G01N24/08
代理机构 代理人
主权项
地址